Breast MRI for detection or diagnosis of primary or recurrent breast cancer

Technol Eval Cent Assess Program Exec Summ. 2004 Apr;19(1):1-9.
No abstract available

MeSH terms

  • Biopsy
  • Blue Cross Blue Shield Insurance Plans
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / diagnostic imaging
  • Device Approval
  • Female
  • Humans
  • Insurance Coverage
  • Magnetic Resonance Imaging*
  • Mammary Glands, Human / pathology*
  • Mammography*
  • Neoplasm Recurrence, Local / diagnosis*
  • Outcome Assessment, Health Care
  • Risk Factors
  • Sensitivity and Specificity
  • Technology Assessment, Biomedical
  • United States
  • United States Food and Drug Administration